There are 449 resources available
156P - The impact of the COVID-19 pandemic on the treatment patterns of patients with stage III unresectable non-small cell lung cancer
Presenter: Paolo Borghetti
Session: Poster Display session
157P - Durvalumab impacts progression-free survival but not local control in patients with inoperable NSCLC stage III: Real-world data from the Austrian radio-oncological lung cancer study association registry (ALLSTAR)
Presenter: Franz Zehentmayr
Session: Poster Display session
158P - Neoadjuvant treatment in stage III NSCLC: Comparison with NADIM 2 trial as a gold standard
Presenter: Francesc Casas
Session: Poster Display session
159P - Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treatment in IB-IIIB lung squamous cell carcinoma
Presenter: Jia Liu
Session: Poster Display session
160P - Perioperative and patient reported outcomes of robotic-assisted and video-assisted thoracoscopic surgery for patients with NSCLC receiving neoadjuvant immunotherapy: A real-world cohort study
Presenter: Shaowei Wu
Session: Poster Display session
162TiP - An update on the VIGILANCE study: Developing circulating and imaging biomarkers towards personalised radiotherapy in lung cancer
Presenter: Ashley Horne
Session: Poster Display session
163P - Decoding the tumor immune microenvironment to unleash effective immunotherapy avenues for epithelioid malignant pleural mesothelioma
Presenter: Cara Haymaker
Session: Poster Display session
164P - Circulating cytokines levels as predictive biomarkers in pleural mesothelioma: Preliminary data from a prospective translational study
Presenter: Daniela Scattolin
Session: Poster Display session
165P - Tissue genomic profiling of pleural mesothelioma patients treated with immunotherapy: Unraveling genetic alterations and complexity
Presenter: Paolo Ambrosini
Session: Poster Display session